Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk - Lindmark, F; Zheng, S L; Wiklund, F; Bälter, K A; Sun, J; Chang, B; Hedelin, M; Clark, J; Johansson, J-E; Meyers, D A; Adami, H-O; Isaacs, W; et al. (British journal of cancer, 2005)
Keywords: Aged; association; Biomedical and Life Sciences; Biomedicine; Cancer Research; Case-Control Studies; Cytokines; Drug Resistance; Epidemiology; Genes; Genetic Variation; Genetics and Genomics; Genotype; Haplotypes; Humans; IL1-RN; ILI-RN; Inflammation; Inflammation - genetics; Interleukin 1 Receptor Antagonist Protein; Male; Medical research; Molecular Medicine; Odds Ratio; Oncology; Polymorphism, Single Nucleotide; Prostate cancer; Prostatic Neoplasms - genetics; Prostatic Neoplasms - immunology; Risk Factors; Sialoglycoproteins - genetics; Sialoglycoproteins - physiology; Signal transduction; SNPs; Sweden; Urology; Sweden; United States--US; SNPs; association; prostate cancer; inflammation